Avid Bioservices Performance
| CDMODelisted Stock | USD 12.49 0.00 0.00% |
Avid Bioservices has a performance score of 21 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.14, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Avid Bioservices' returns are expected to increase less than the market. However, during the bear market, the loss of holding Avid Bioservices is expected to be smaller as well. Avid Bioservices right now shows a risk of 0.23%. Please confirm Avid Bioservices downside variance, and the relationship between the sortino ratio and accumulation distribution , to decide if Avid Bioservices will be following its price patterns.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Avid Bioservices are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy primary indicators, Avid Bioservices is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 38.9 M |
Avid |
Avid Bioservices Relative Risk vs. Return Landscape
If you would invest 1,227 in Avid Bioservices on December 22, 2024 and sell it today you would earn a total of 22.00 from holding Avid Bioservices or generate 1.79% return on investment over 90 days. Avid Bioservices is currently generating 0.0615% in daily expected returns and assumes 0.227% risk (volatility on return distribution) over the 90 days horizon. In different words, 2% of stocks are less volatile than Avid, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Avid Bioservices Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avid Bioservices' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Avid Bioservices, and traders can use it to determine the average amount a Avid Bioservices' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2712
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | CDMO | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 0.23 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.27 actual daily | 21 79% of assets perform better |
Based on monthly moving average Avid Bioservices is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avid Bioservices by adding it to a well-diversified portfolio.
Avid Bioservices Fundamentals Growth
Avid Stock prices reflect investors' perceptions of the future prospects and financial health of Avid Bioservices, and Avid Bioservices fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avid Stock performance.
| Return On Equity | -1.16 | |||
| Return On Asset | -0.0305 | |||
| Profit Margin | (1.01) % | |||
| Operating Margin | (0.06) % | |||
| Current Valuation | 971.01 M | |||
| Shares Outstanding | 63.96 M | |||
| Price To Earning | 10.76 X | |||
| Price To Book | 17.83 X | |||
| Price To Sales | 5.61 X | |||
| Revenue | 139.91 M | |||
| EBITDA | (11.48 M) | |||
| Cash And Equivalents | 115.14 M | |||
| Cash Per Share | 1.85 X | |||
| Total Debt | 207.83 M | |||
| Debt To Equity | 1.02 % | |||
| Book Value Per Share | 0.96 X | |||
| Cash Flow From Operations | 10.95 M | |||
| Earnings Per Share | (2.41) X | |||
| Total Asset | 336.56 M | |||
| Retained Earnings | (571.87 M) | |||
| Current Asset | 25.65 M | |||
| Current Liabilities | 10.9 M | |||
About Avid Bioservices Performance
By examining Avid Bioservices' fundamental ratios, stakeholders can obtain critical insights into Avid Bioservices' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Avid Bioservices is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.Things to note about Avid Bioservices performance evaluation
Checking the ongoing alerts about Avid Bioservices for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Avid Bioservices help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avid Bioservices is not yet fully synchronised with the market data | |
| Avid Bioservices has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 139.91 M. Net Loss for the year was (140.75 M) with profit before overhead, payroll, taxes, and interest of 8.93 M. | |
| Over 99.0% of the company shares are held by institutions such as insurance companies |
- Analyzing Avid Bioservices' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avid Bioservices' stock is overvalued or undervalued compared to its peers.
- Examining Avid Bioservices' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avid Bioservices' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avid Bioservices' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avid Bioservices' stock. These opinions can provide insight into Avid Bioservices' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Consideration for investing in Avid Stock
If you are still planning to invest in Avid Bioservices check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Avid Bioservices' history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| CEOs Directory Screen CEOs from public companies around the world |